Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
PIII vs MOH vs CNC vs ALHC vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
PIII vs MOH vs CNC vs ALHC vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $10M | $9.69B | $27.63B | $3.66B | $344.90B |
| Revenue (TTM) | $1.44B | $45.08B | $198.10B | $4.26B | $449.71B |
| Net Income (TTM) | $-131M | $188M | $-6.44B | $20M | $12.04B |
| Gross Margin | 48.2% | 9.6% | 14.9% | 9.0% | 18.8% |
| Operating Margin | -17.6% | 1.2% | -3.7% | 0.8% | 4.2% |
| Forward P/E | — | 36.1x | 16.4x | 101.8x | 20.7x |
| Total Debt | $166M | $3.95B | $18.78B | $338M | $78.39B |
| Cash & Equiv. | $39M | $4.25B | $17.89B | $578M | $24.36B |
PIII vs MOH vs CNC vs ALHC vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| P3 Health Partners … (PIII) | 100 | 0.7 | -99.3% |
| Molina Healthcare, … (MOH) | 100 | 72.9 | -27.1% |
| Centene Corporation (CNC) | 100 | 90.6 | -9.4% |
| Alignment Healthcar… (ALHC) | 100 | 67.6 | -32.4% |
| UnitedHealth Group … (UNH) | 100 | 95.3 | -4.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PIII vs MOH vs CNC vs ALHC vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PIII ranks third and is worth considering specifically for stability.
- Beta 0.09 vs ALHC's 0.81, lower leverage
Among these 5 stocks, MOH doesn't own a clear edge in any measured category.
CNC is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.41, Low D/E 93.6%, current ratio 1.68x
- Beta 0.41, current ratio 1.68x
- Lower P/E (16.4x vs 20.7x)
ALHC is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- 46.1% revenue growth vs MOH's 11.7%
- +16.3% vs PIII's -58.5%
UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 25 yrs, beta 0.60, yield 2.3%
- 228.3% 10Y total return vs MOH's 294.2%
- 2.7% margin vs PIII's -9.1%
- 2.3% yield; 25-year raise streak; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.1% revenue growth vs MOH's 11.7% | |
| Value | Lower P/E (16.4x vs 20.7x) | |
| Quality / Margins | 2.7% margin vs PIII's -9.1% | |
| Stability / Safety | Beta 0.09 vs ALHC's 0.81, lower leverage | |
| Dividends | 2.3% yield; 25-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +16.3% vs PIII's -58.5% | |
| Efficiency (ROA) | 3.9% ROA vs PIII's -19.2%, ROIC 9.2% vs -60.2% |
PIII vs MOH vs CNC vs ALHC vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PIII vs MOH vs CNC vs ALHC vs UNH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALHC leads in 2 of 6 categories
UNH leads 2 • PIII leads 0 • MOH leads 0 • CNC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALHC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 311.2x PIII's $1.4B. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to PIII's -9.1%. On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.4B | $45.1B | $198.1B | $4.3B | $449.7B |
| EBITDAEarnings before interest/tax | -$171M | $710M | -$5.9B | $66M | $23.2B |
| Net IncomeAfter-tax profit | -$131M | $188M | -$6.4B | $20M | $12.0B |
| Free Cash FlowCash after capex | -$123M | $251M | $6.3B | $237M | $19.7B |
| Gross MarginGross profit ÷ Revenue | +48.2% | +9.6% | +14.9% | +9.0% | +18.8% |
| Operating MarginEBIT ÷ Revenue | -17.6% | +1.2% | -3.7% | +0.8% | +4.2% |
| Net MarginNet income ÷ Revenue | -9.1% | +0.4% | -3.3% | +0.5% | +2.7% |
| FCF MarginFCF ÷ Revenue | -8.5% | +0.6% | +3.2% | +5.6% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.7% | -3.1% | +7.1% | +33.3% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.4% | -95.0% | +18.3% | +2.1% | +0.7% |
Valuation Metrics
Evenly matched — PIII and CNC each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 20.8x trailing earnings, MOH trades at a 27% valuation discount to UNH's 28.7x P/E. On an enterprise value basis, MOH's 9.6x EV/EBITDA is more attractive than ALHC's 75.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $10M | $9.7B | $27.6B | $3.7B | $344.9B |
| Enterprise ValueMkt cap + debt − cash | $138M | $9.4B | $28.5B | $3.4B | $398.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.07x | 20.85x | -4.11x | -4845.95x | 28.72x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 36.06x | 16.37x | 101.82x | 20.71x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 9.62x | — | 75.68x | 17.10x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 0.21x | 0.14x | 0.93x | 0.77x |
| Price / BookPrice ÷ Book value/share | 0.07x | 2.32x | 1.37x | 19.80x | 3.40x |
| Price / FCFMarket cap ÷ FCF | — | — | 6.39x | 32.37x | 21.46x |
Profitability & Efficiency
UNH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-7 for PIII. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x. On the Piotroski fundamental quality scale (0–9), CNC scores 6/9 vs PIII's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -6.9% | +4.4% | -28.6% | +11.5% | +11.5% |
| ROA (TTM)Return on assets | -19.2% | +1.2% | -7.9% | +1.8% | +3.9% |
| ROICReturn on invested capital | -60.2% | +17.4% | -21.6% | — | +9.2% |
| ROCEReturn on capital employed | -75.6% | +9.8% | -14.6% | +2.9% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.11x | 0.97x | 0.94x | 1.89x | 0.77x |
| Net DebtTotal debt minus cash | $127M | -$298M | $889M | -$240M | $54.0B |
| Cash & Equiv.Liquid assets | $39M | $4.2B | $17.9B | $578M | $24.4B |
| Total DebtShort + long-term debt | $166M | $4.0B | $18.8B | $338M | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | -5.02x | 2.12x | -9.03x | 1.27x | 4.71x |
Total Returns (Dividends Reinvested)
ALHC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UNH five years ago would be worth $9,911 today (with dividends reinvested), compared to $73 for PIII. Over the past 12 months, ALHC leads with a +16.3% total return vs PIII's -58.5%. The 3-year compound annual growth rate (CAGR) favors ALHC at 35.4% vs PIII's -66.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.4% | +4.2% | +33.9% | -11.3% | +13.6% |
| 1-Year ReturnPast 12 months | -58.5% | -42.9% | -10.3% | +16.3% | +0.8% |
| 3-Year ReturnCumulative with dividends | -96.3% | -37.0% | -18.0% | +148.0% | -17.8% |
| 5-Year ReturnCumulative with dividends | -99.3% | -30.8% | -19.6% | -16.6% | -0.9% |
| 10-Year ReturnCumulative with dividends | -99.3% | +294.2% | +84.5% | +3.6% | +228.3% |
| CAGR (3Y)Annualised 3-year return | -66.7% | -14.3% | -6.4% | +35.4% | -6.3% |
Risk & Volatility
Evenly matched — MOH and UNH each lead in 1 of 2 comparable metrics.
Risk & Volatility
MOH is the less volatile stock with a -0.06 beta — it tends to amplify market swings less than ALHC's 0.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 97.2% from its 52-week high vs PIII's 31.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.09x | -0.06x | 0.41x | 0.81x | 0.60x |
| 52-Week HighHighest price in past year | $11.30 | $333.00 | $64.15 | $23.87 | $390.92 |
| 52-Week LowLowest price in past year | $1.52 | $121.06 | $25.08 | $11.63 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +31.4% | +55.8% | +87.2% | +75.1% | +97.2% |
| RSI (14)Momentum oscillator 0–100 | 69.5 | 69.6 | 81.6 | 38.1 | 76.9 |
| Avg Volume (50D)Average daily shares traded | 62K | 1.4M | 5.8M | 3.6M | 7.9M |
Analyst Outlook
UNH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: PIII as "Buy", MOH as "Buy", CNC as "Buy", ALHC as "Buy", UNH as "Buy". Consensus price targets imply 252.3% upside for PIII (target: $13) vs -10.7% for MOH (target: $166). UNH is the only dividend payer here at 2.29% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $12.50 | $166.09 | $51.00 | $24.83 | $385.43 |
| # AnalystsCovering analysts | 4 | 38 | 43 | 16 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +2.3% |
| Dividend StreakConsecutive years of raises | — | — | 1 | — | 25 |
| Dividend / ShareAnnual DPS | — | — | — | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +10.3% | +1.7% | 0.0% | +1.6% |
ALHC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). UNH leads in 2 (Profitability & Efficiency, Analyst Outlook). 2 tied.
PIII vs MOH vs CNC vs ALHC vs UNH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PIII or MOH or CNC or ALHC or UNH a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 11. 7% for Molina Healthcare, Inc. (MOH). Molina Healthcare, Inc. (MOH) offers the better valuation at 20. 8x trailing P/E (36. 1x forward), making it the more compelling value choice. Analysts rate P3 Health Partners Inc. (PIII) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PIII or MOH or CNC or ALHC or UNH?
On trailing P/E, Molina Healthcare, Inc.
(MOH) is the cheapest at 20. 8x versus UnitedHealth Group Incorporated at 28. 7x. On forward P/E, Centene Corporation is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PIII or MOH or CNC or ALHC or UNH?
Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -0.
9%, compared to -99. 3% for P3 Health Partners Inc. (PIII). Over 10 years, the gap is even starker: MOH returned +294. 2% versus PIII's -99. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PIII or MOH or CNC or ALHC or UNH?
By beta (market sensitivity over 5 years), Molina Healthcare, Inc.
(MOH) is the lower-risk stock at -0. 06β versus Alignment Healthcare, Inc. 's 0. 81β — meaning ALHC is approximately -1541% more volatile than MOH relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PIII or MOH or CNC or ALHC or UNH?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus 11. 7% for Molina Healthcare, Inc. (MOH). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PIII or MOH or CNC or ALHC or UNH?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -9. 1% for P3 Health Partners Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -21. 4% for PIII. At the gross margin level — before operating expenses — PIII leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PIII or MOH or CNC or ALHC or UNH more undervalued right now?
On forward earnings alone, Centene Corporation (CNC) trades at 16.
4x forward P/E versus 101. 8x for Alignment Healthcare, Inc. — 85. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PIII: 252. 3% to $12. 50.
08Which pays a better dividend — PIII or MOH or CNC or ALHC or UNH?
In this comparison, UNH (2.
3% yield) pays a dividend. PIII, MOH, CNC, ALHC do not pay a meaningful dividend and should not be held primarily for income.
09Is PIII or MOH or CNC or ALHC or UNH better for a retirement portfolio?
For long-horizon retirement investors, Molina Healthcare, Inc.
(MOH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), +294. 2% 10Y return). Both have compounded well over 10 years (MOH: +294. 2%, ALHC: +3. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PIII and MOH and CNC and ALHC and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PIII is a small-cap high-growth stock; MOH is a small-cap quality compounder stock; CNC is a mid-cap high-growth stock; ALHC is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while PIII, MOH, CNC, ALHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.